FDA Import Refusal 799-9265245-5/20003/1 — AstraZeneca Canada Inc.
The FDA refused shipment 799-9265245-5/20003/1 from AstraZeneca Canada Inc. (Canada) on Dec 5, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 5, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75